Table 1.

Distribution of patient features

Cases (n = 30)Controls (n = 24)
Preoperative PSA
    Median10.9 ng/mL6.6 ng/mL
    Range4.7-66.73.2-24.1
    % >1530%21%
Pathologic Gleason sum
    5-67%17%
    770%54%
        3+443%42%
        4+327%12%
    8-923%29%
Percent positive margins47%25%
Percent seminal vesicle involvement38%X
Percent extracapsular extension70%46%
Percent positive lymph nodes50%X
Year of RP
    Range1989-20041994-2002
    <200040%58%
    ≥200060%42%
Median follow-upX63.5 mo
    RangeX27-148
    % >5 yX63%

NOTE: X, determined by study design.